This is the authors' abstract. We don't add key points for this paper.
Lipid droplet (LD) size is a key determinant of hepatic lipid metabolism, yet the molecular programming routing size-defined subpopulations to distinct fates remains unclear. Here we show that a fractionation workflow resolves hepatic LDs by size and organelle association, defining a high-confidence intrinsic LD proteome. Moreover, comparative proteomics of fasted livers reveals a clear ‘division of labor’: Large LDs (L-LDs) function as specialized mitochondrion-coupled ‘putative fueling hubs’, whereas small LDs (S-LDs) serve as lysosome-coupled ‘putative trafficking and turnover hubs’. This interaction map is highly plastic; metabolic stress (fasting or steatosis) triggers a programmatic remodeling where lysosomal machinery is inducibly recruited to S-LDs. Crucially, in vivo stress recruits mitochondria to both pools, supporting a ‘parallel programs’ model where S-LD-associated mitochondria are hypothesized to power the energy-intensive degradative machinery. These findings establish that metabolic state leverages LD size to direct organelle partnerships, nominating the small-LD lysosomal axis as a critical regulatory node in metabolic-associated fatty liver disease (MAFLD).
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Liao et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: